Silvana Canevari

Silvana Canevari

UNVERIFIED PROFILE

Are you Silvana Canevari?   Register this Author

Register author
Silvana Canevari

Silvana Canevari

Publications by authors named "Silvana Canevari"

Are you Silvana Canevari?   Register this Author

100Publications

1880Reads

25Profile Views

Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell Carcinoma.

Cancers (Basel) 2019 Jul 26;11(8). Epub 2019 Jul 26.

Integrated Biology Platform, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11081057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721309PMC
July 2019

Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial.

Oral Oncol 2018 07 28;82:144-151. Epub 2018 May 28.

Fondazione IRCCS Istituto Nazionale dei Tumori, Integrated Biology Platform, Department of Applied Research and Technology Development, Via Amadeo 42, I-20133 Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2018.05.013DOI Listing
July 2018

New transcriptional-based insights into the pathogenesis of desmoplastic small round cell tumors (DSRCTs).

Oncotarget 2017 May;8(20):32492-32504

Department of Diagnostic Pathology and Laboratory Medicine, Laboratory of Experimental Molecular Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464804PMC
May 2017

Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?

Curr Treat Options Oncol 2017 05;18(5):32

Functional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0472-2DOI Listing
May 2017

Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer.

Genes (Basel) 2017 Jan 14;8(1). Epub 2017 Jan 14.

Functional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/genes8010035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295029PMC
January 2017

Applicability of Under Vacuum Fresh Tissue Sealing and Cooling to Omics Analysis of Tumor Tissues.

Biopreserv Biobank 2016 Dec 12;14(6):480-490. Epub 2016 Jul 12.

1 Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan, Italy .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2015.0093DOI Listing
December 2016

Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab.

Clin Cancer Res 2016 08 26;22(15):3961-70. Epub 2016 Feb 26.

Functional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2547DOI Listing
August 2016

Targeting folate receptor alpha for cancer treatment.

Oncotarget 2016 08;7(32):52553-52574

St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London, Guy's Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9651DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239573PMC
August 2016

Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients.

Anticancer Res 2016 Aug;36(8):4155-63

Department of Morphofunctional Sciences - Histology, Pathology, "Grigore T. Popa" University of Medicine and Pharmacy, Iassy, Romania

View Article

Download full-text PDF

Source
August 2016

Choline Metabolism Alteration: A Focus on Ovarian Cancer.

Front Oncol 2016 22;6:153. Epub 2016 Jun 22.

Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2016.00153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916225PMC
July 2016

Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression.

Biochim Biophys Acta 2016 Mar 14;1863(3):483-489. Epub 2015 Sep 14.

Department of Biomedical and Biotechnological Sciences, Section of General & Clinical Pathology and Oncology, University of Catania, Catania, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01674889150031
Publisher Site
http://dx.doi.org/10.1016/j.bbamcr.2015.09.018DOI Listing
March 2016

Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma.

Clin Genitourin Cancer 2016 Feb 7;14(1):e81-90. Epub 2015 Aug 7.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.07.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003615PMC
February 2016

Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen.

Immunol Lett 2015 Nov 25;168(1):105-10. Epub 2015 Sep 25.

Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2015.09.012DOI Listing
November 2015

Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data.

Oncotarget 2015 Apr;6(11):9627-42

Functional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496244PMC
http://dx.doi.org/10.18632/oncotarget.3301DOI Listing
April 2015

Identification of a gene expression driven progression pathway in myxoid liposarcoma.

Oncotarget 2014 Aug;5(15):5965-77

Laboratory of Experimental Molecular Pathology, Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171605PMC
http://dx.doi.org/10.18632/oncotarget.2023DOI Listing
August 2014

The value of PAX8 and WT1 molecules in ovarian cancer diagnosis.

Rom J Morphol Embryol 2013 ;54(1):17-27

Department of Morphofunctional Sciences, Histology, Morphopathology, “Grigore T. Popa” University of Medicine and Pharmacy, Iassy, Romania.

View Article

Download full-text PDF

Source
http://www.rjme.ro/RJME/resources/files/540113017027.pdf
Web Search
May 2014

Choline metabolic profiling by magnetic resonance spectroscopy.

Methods Mol Biol 2013 ;1049:255-70

Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-62703-547-7_19DOI Listing
March 2014

Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression.

Cancer Res 2014 Jan;74(1):130-40

Authors' Affiliations: Immunotherapy Unit; Department of Pathology; Functional Genomics Unit; Immunobiology of Human Tumors Unit; Department of Medical Statistics and University of Milan, Medical Statistics Biometry and Bioinformatics Unit; Department of Surgery, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; Microscopy and Image Analysis, University of Milan Bicocca, Milan; Department of Immunohematology and Transfusion Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1672DOI Listing
January 2014

Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation.

PLoS One 2013 6;8(3):e58849. Epub 2013 Mar 6.

Functional Genomics Core Facility, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058849PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590172PMC
September 2013

Bevacizumab treatment and quality of life in advanced ovarian cancer.

Future Oncol 2013 Jul;9(7):951-4

Molecular Therapies, Department of Experimental Oncology & Molecular Medicine, Ondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.13.77DOI Listing
July 2013

An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response.

BMC Genomics 2013 Jul 26;14:508. Epub 2013 Jul 26.

Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2
Publisher Site
http://dx.doi.org/10.1186/1471-2164-14-508DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728068PMC
July 2013

Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.

Int J Cancer 2013 Jun 13;132(11):2597-605. Epub 2012 Dec 13.

Department of Integrated Oncological Therapies, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27948DOI Listing
June 2013

Feasibility of circulating miRNA microarray analysis from archival plasma samples.

Anal Biochem 2013 Jun 13;437(2):123-5. Epub 2013 Mar 13.

Unit of Biomarkers, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ab.2013.03.002DOI Listing
June 2013

Measuring microRNA expression levels in oncology: from samples to data analysis.

Crit Rev Oncog 2013 ;18(4):273-87

Functional Genomics Core Facility, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
June 2013

Redirection of T-cell effector functions for cancer therapy: bispecific antibodies and chimeric antigen receptors.

Future Oncol 2013 Apr;9(4):527-39

Unit of Molecular Therapies, Department of Experimental Oncology & Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.12.203DOI Listing
April 2013

Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition.

Biochem Pharmacol 2012 Jan 29;83(1):27-36. Epub 2011 Sep 29.

Molecular Pharmacology Unit, Dept. Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2011.09.021DOI Listing
January 2012

Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.

J Invest Dermatol 2011 Dec 28;131(12):2448-57. Epub 2011 Jul 28.

Unit of Immunobiology of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2011.218DOI Listing
December 2011

Antitumor effects of a human dimeric antibody fragment 131I-AFRA-DFM5.3 in a mouse model for ovarian cancer.

J Nucl Med 2011 Dec 8;52(12):1938-46. Epub 2011 Nov 8.

Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.110.086819DOI Listing
December 2011

MR evaluation of response to targeted treatment in cancer cells.

NMR Biomed 2011 Jul 8;24(6):648-72. Epub 2011 Mar 8.

Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nbm.1658DOI Listing
July 2011

Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple Myeloma.

For Immunopathol Dis Therap 2011 Apr;2(2)

Department of Microbiology, Immunology and Molecular Genetics, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1615/ForumImmunDisTher.v2.i2.90DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839863PMC
April 2011

miRNA control of apoptotic programs: focus on ovarian cancer.

Expert Rev Mol Diagn 2011 Apr;11(3):277-86

Department of Experimental Oncology and Molecular Medicine-Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. delia.mezzanzanica@ istitutotumori.mi.it

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erm.11.1DOI Listing
April 2011

Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications.

Int J Biochem Cell Biol 2010 Aug 24;42(8):1262-72. Epub 2009 Dec 24.

Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2009.12.017DOI Listing
August 2010

Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.

Cell Cycle 2010 Mar 15;9(6):1194-206. Epub 2010 Mar 15.

Unit of Molecular Therapies, Experimental Oncology and Molecular Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.9.6.11108DOI Listing
March 2010

Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer.

Int J Biochem Cell Biol 2010 Feb 22;42(2):210-3. Epub 2009 Nov 22.

Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, Milan, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S135727250900345
Publisher Site
http://dx.doi.org/10.1016/j.biocel.2009.11.015DOI Listing
February 2010

Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.

Cell Cycle 2010 Feb;9(3):557-63

Unit of Molecular Therapies, Department of Experimental Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.9.3.10554DOI Listing
February 2010

(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.

Nucl Med Biol 2009 Oct 29;36(7):759-70. Epub 2009 Jul 29.

Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nucmedbio.2009.05.004DOI Listing
October 2009

c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome.

Endocr Relat Cancer 2009 Jun 25;16(2):443-53. Epub 2009 Mar 25.

Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-08-0218DOI Listing
June 2009

The involvement of the transcription factor Yin Yang 1 in cancer development and progression.

Cell Cycle 2009 May 26;8(9):1367-72. Epub 2009 May 26.

Unit of Molecular Therapies, Department of Experimental Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.8.9.8314DOI Listing
May 2009

Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.

Cancer Immunol Immunother 2009 Apr 15;58(4):531-46. Epub 2008 Aug 15.

Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0575-5DOI Listing
April 2009

Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells.

Neoplasia 2008 Dec;10(12):1481-92, 3p following 1492

Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586698PMC
http://dx.doi.org/10.1593/neo.81004DOI Listing
December 2008

Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.

Clin Cancer Res 2008 Nov;14(22):7470-80

Unit of Molecular Therapies, Department of Experimental Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0870DOI Listing
November 2008

Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.

Cancer Res 2008 Aug;68(16):6541-9

Section of Molecular and Cellular Imaging, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-6763DOI Listing
August 2008

The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells.

Mol Cancer Res 2007 Dec;5(12):1246-53

Department of Translational Oncology, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-07-0060DOI Listing
December 2007

Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells.

Exp Cell Res 2007 Apr 15;313(7):1307-17. Epub 2007 Feb 15.

Unit of Molecular Therapies, Department of Experimental Oncology, Istituto Nazionale Tumori, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2007.02.005DOI Listing
April 2007

Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.

Mol Cancer Ther 2007 Feb;6(2):762-72

Unit of Molecular Therapies, Department of Experimental Oncology, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-06-0357DOI Listing
February 2007

DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues.

Mol Cell Biol 2006 Nov 28;26(21):7832-45. Epub 2006 Aug 28.

Department of Experimental Oncology, Istituto Nazionale Tumori, 20133 Milano, Italy.

View Article

Download full-text PDF

Source
http://mcb.asm.org/cgi/doi/10.1128/MCB.00534-06
Publisher Site
http://dx.doi.org/10.1128/MCB.00534-06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1636737PMC
November 2006

New potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studies.

Cancer Res 2006 Nov 6;66(22):10709-19. Epub 2006 Nov 6.

Unit of Molecular Therapies, Department of Experimental Oncology, Istituto Nazionale Tumori FIRC di Oncologia Molecolare, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-1327DOI Listing
November 2006

Molecular predictors of response and outcome in ovarian cancer.

Crit Rev Oncol Hematol 2006 Oct 7;60(1):19-37. Epub 2006 Jul 7.

Unit of Molecular Therapies, Department of Experimental Oncology, Istituto Nazionale Tumori, 20133-Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2006.03.003DOI Listing
October 2006

The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer.

Clin Cancer Res 2006 Oct;12(20 Pt 1):6170-8

Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0992DOI Listing
October 2006

Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.

Cancer Res 2006 Apr;66(7):3876-83

Department of Physiology and Pathology, University of Trieste, Via Fleming 22, 34127 Trieste, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-3434DOI Listing
April 2006

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas.

Cancer Immunol Immunother 2005 Dec 31;54(12):1200-13. Epub 2005 May 31.

Unit of Nuclear Medicine, Istituto Nazionale Tumori, via Venezian 1, 20133 Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-005-0693-2DOI Listing
December 2005

Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases.

Am J Pathol 2005 Nov;167(5):1411-27

Unit of Molecular Therapies, Department of Experimental Oncology, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1603782PMC
http://dx.doi.org/10.1016/S0002-9440(10)61228-XDOI Listing
November 2005

Alterations of choline phospholipid metabolism in ovarian tumor progression.

Cancer Res 2005 Oct;65(20):9369-76

Section of Molecular and Cellular Imaging, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1146DOI Listing
October 2005

Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody.

J Cell Sci 2005 Apr 15;118(Pt 7):1515-25. Epub 2005 Mar 15.

Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi 10, 16132 Genova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.02280DOI Listing
April 2005

Highly efficient redirected anti-tumor activity of human lymphocytes transduced with a completely human chimeric immune receptor.

J Gene Med 2005 Feb;7(2):158-70

Molecular Therapies Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jgm.647DOI Listing
February 2005

Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids.

Farmaco 2004 Nov;59(11):869-78

Dipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, Via Pietro Giuria 9, 10125 Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.farmac.2004.06.007DOI Listing
November 2004

A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing.

Oncogene 2004 Sep;23(45):7552-60

Istituto Nazionale per la Ricerca sul Cancro, Largo Rosanna Benzi 10, 16132 Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208036DOI Listing
September 2004